BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 21073128)

  • 1. McCune-Albright syndrome (MAS): early and extensive bone fibrous dysplasia involvement and "mistaken identity" oophorectomy.
    Gucev Z; Tasic V; Jancevska A; Krstevska-Konstantinova M; Pop-Jordanova N
    J Pediatr Endocrinol Metab; 2010 Aug; 23(8):837-42. PubMed ID: 21073128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis and management of precocious puberty in atypical presentations of McCune-Albright syndrome: a case series review.
    Bercaw-Pratt JL; Moorjani TP; Santos XM; Karaviti L; Dietrich JE
    J Pediatr Adolesc Gynecol; 2012 Feb; 25(1):e9-e13. PubMed ID: 22051789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partial benefit of anastrozole in the long-term treatment of precocious puberty in McCune-Albright syndrome.
    Alves C; Silva SF
    J Pediatr Endocrinol Metab; 2012; 25(3-4):323-5. PubMed ID: 22774233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oophorectomy in McCune-Albright syndrome: a case of mistaken identity.
    Nabhan ZM; West KW; Eugster EA
    J Pediatr Surg; 2007 Sep; 42(9):1578-83. PubMed ID: 17848252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effective aromatase inhibition by anastrozole in a patient with gonadotropin-independent precocious puberty in McCune-Albright syndrome.
    Roth C; Freiberg C; Zappel H; Albers N
    J Pediatr Endocrinol Metab; 2002; 15 Suppl 3():945-8. PubMed ID: 12199354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and endocrine characteristics and genetic analysis of Korean children with McCune-Albright syndrome: a retrospective cohort study.
    Cho EK; Kim J; Yang A; Ki CS; Lee JE; Cho SY; Jin DK
    Orphanet J Rare Dis; 2016 Aug; 11(1):113. PubMed ID: 27506760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of precocious puberty in the McCune-Albright syndrome with the aromatase inhibitor testolactone.
    Feuillan PP; Foster CM; Pescovitz OH; Hench KD; Shawker T; Dwyer A; Malley JD; Barnes K; Loriaux DL; Cutler GB
    N Engl J Med; 1986 Oct; 315(18):1115-9. PubMed ID: 3093862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolving diagnosis of McCune-Albright syndrome. atypical presentation and follow up.
    Medina YN; Rapaport R
    J Pediatr Endocrinol Metab; 2009 Apr; 22(4):373-7. PubMed ID: 19554813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. McCune-Albright syndrome onset with vaginal bleeding.
    Van Doan N; Minh Duc N; Kim Ngan V; Van Anh N
    BMJ Case Rep; 2021 Jul; 14(7):. PubMed ID: 34281944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A boy with McCune-Albright syndrome associated with GH secreting pituitary microadenoma. Clinical findings and response to treatment.
    Papadopoulou M; Doula S; Kitsios K; Kaltsas T; Kosta K
    Hormones (Athens); 2006; 5(3):205-9. PubMed ID: 16950755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Letrozole treatment of precocious puberty in girls with the McCune-Albright syndrome: a pilot study.
    Feuillan P; Calis K; Hill S; Shawker T; Robey PG; Collins MT
    J Clin Endocrinol Metab; 2007 Jun; 92(6):2100-6. PubMed ID: 17405850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Precocious puberty caused by McCune-Albright syndrome in a girl aged 6 years and 9 months].
    Wikiera B; Wawro J; Noczyńska A
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(1):63-7. PubMed ID: 16704864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. McCune-Albright Syndrome: A Case Report and Review of Literature.
    Nicolaides NC; Kontou M; Vasilakis IA; Binou M; Lykopoulou E; Kanaka-Gantenbein C
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eight-year follow-up of a girl with McCune-Albright syndrome.
    Aycan Z; Önder A; Çetinkaya S
    J Clin Res Pediatr Endocrinol; 2011; 3(1):40-2. PubMed ID: 21448334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. McCune-Albright syndrome.
    Dumitrescu CE; Collins MT
    Orphanet J Rare Dis; 2008 May; 3():12. PubMed ID: 18489744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy and safety of letrozole in treatment of McCune-Albright syndrome girls with peripheral precocious puberty].
    Xu D; Lu W; Wang X; Wang J; Xie Y; Dong Z; Wang W
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2020 May; 49(3):291-296. PubMed ID: 32762164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian function in girls with McCune-Albright syndrome.
    Foster CM; Feuillan P; Padmanabhan V; Pescovitz OH; Beitins IZ; Comite F; Shawker TH; Loriaux DL; Cutler GB
    Pediatr Res; 1986 Sep; 20(9):859-63. PubMed ID: 3092175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The aromatase inhibitor anastrozole is ineffective in the treatment of precocious puberty in girls with McCune-Albright syndrome.
    Mieszczak J; Lowe ES; Plourde P; Eugster EA
    J Clin Endocrinol Metab; 2008 Jul; 93(7):2751-4. PubMed ID: 18397987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extent of Extraskeletal Manifestations of Fibrous Dysplasia/McCune-Albright Syndrome in Patients with Mazabraud's Syndrome.
    Hagelstein-Rotman M; Appelman-Dijkstra NM; Boyce AM; Chapurlat R; Dur NBJ; Gensburger D; Majoor BCJ; van de Sande MAJ; Dijkstra PDS
    Calcif Tissue Int; 2022 Mar; 110(3):334-340. PubMed ID: 34854944
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.